Evusheld Boosts Antibodies Against COVID-19 in Vaccinated Patients

Evusheld Boosts Antibodies Against COVID-19 in Vaccinated Patients

327592

Evusheld Boosts Antibodies Against COVID-19 in Vaccinated Patients

Treatment with Evusheld (tixagevimab co-packaged with cilgavimab) after COVID-19 vaccination significantly boosted the levels of antibodies against the virus among people with multiple sclerosis (MS) who were taking B-cell targeted therapies, a small study showed. “This is important as it provides a different strategy for protection against COVID-19,” the scientists wrote. Research has suggested that the virus underlying COVID-19 can infect the nervous system and may contribute to symptom development in some people with MS —…

You must be logged in to read/download the full post.